Skip to main content
Figure 5 | BMC Genomics

Figure 5

From: Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers

Figure 5

Classification of high-grade serous ovarian cancer patients. The patients diagnosed with high-grade serous ovarian cancer were classified using a data-driven method for statistically novel biomarkers (A) FZD1and (B) HGFand common biomarkers (C) COL3A1and (D) EDNRA. Log-rank tests were used to assess the survival statistical significance of the two patient subgroups. Expr: expression.

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us